Literature DB >> 4712497

Behçet's syndrome and oral fibrinolytic therapy.

W J Cunliffe, B E Roberts, B Dodman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4712497      PMCID： PMC1589433          DOI： 10.1136/bmj.2.5864.486-c

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  PHARMACOLOGICAL ENCHANCEMENT OF FIBRINOLYTIC ACTIVITY OF BLOOD.

Authors:  G R FEARNLEY; R CHAKRABARTI
Journal:  J Clin Pathol       Date:  1964-05       Impact factor: 3.411

2.  Treatment of Behcet's syndrome with phenformin and ethyloestrenol.

Authors:  W J Cunliffe; I S Menon
Journal:  Lancet       Date:  1969-06-21       Impact factor: 79.321
  2 in total
  4 in total

Review 1.  Oral ulceration and Behçet's syndrome.

Authors:  T Lehner
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

2.  Behçet's syndrome presenting as myocardial infarction with impaired blood fibrinolysis.

Authors:  S J Hutchison; J J Belch
Journal:  Br Heart J       Date:  1984-12

3.  Behcet's disease.

Authors:  R Graham-Brown
Journal:  Br Med J       Date:  1978-08-19

4.  Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.

Authors:  Ihosvany Fernández-Bello; Francisco J López-Longo; Elena G Arias-Salgado; Víctor Jiménez-Yuste; Nora V Butta
Journal:  Orphanet J Rare Dis       Date:  2013-05-27       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.